| |
| |
|
| Insider
Information: |
Verratti Mark |
| Relationship: |
Chief Commercial Officer |
| City: |
Houston |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
298,715 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,554,502 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
298,715 |
|
|
| Total
Value |
$7,554,502 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
5
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 0.6%
|
 -109.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Commercial Officer |
2024-04-14 |
298,715 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
President, Myriad Neuroscience |
• – – |
2021-09-25 |
4 |
D |
$33.31 |
$224,709 |
D/D |
(6,746) |
205,873 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President Assurex Health Inc. |
• – – |
2020-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,467 |
86,526 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, Myriad Neuroscience |
• – – |
2021-10-09 |
4 |
D |
$30.88 |
$257,539 |
D/D |
(8,340) |
194,019 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2022-10-09 |
4 |
D |
$19.62 |
$164,141 |
D/D |
(8,366) |
228,022 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2023-10-09 |
4 |
D |
$15.01 |
$125,574 |
D/D |
(8,366) |
249,739 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2022-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
243,207 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, Myriad Neuroscience |
• – – |
2021-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
15,441 |
157,130 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, Mental Health |
• – – |
2022-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,238 |
235,873 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, Mental Health |
• – – |
2022-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
22,616 |
216,635 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President Assurex Health Inc. |
• – – |
2020-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
31,258 |
141,689 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President Assurex Health Inc. |
• – – |
2020-09-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,800 |
119,326 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,405 |
267,427 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President Assurex Health Inc. |
• – – |
2017-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
50,000 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President Assurex Health Inc. |
• – – |
2018-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
89,200 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, Myriad Neuroscience |
• – – |
2021-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
56,571 |
212,619 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
58,631 |
308,370 |
0 |
- |
|
41 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
